Drug Product
Excipients & Specialty Ingredients
Company Overview
About
Codexis, Inc. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:United States
Founded:2010
Employees:2,331
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval RN9M72
PMDA · #APR-O6R9DDQD · 2022-12-01
Drug Approval 4H4KK5
PMDA · #APR-L6O30WER · 2020-08-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-8EUUS8TJ
Issued: 2020-11-20
Expires: 2025-01-03
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-MCCAFHV3
Issued: 2020-03-03
Expires: 2025-08-01
Loading CDMO intelligence...
Key facts about Codexis, Inc.
- Codexis, Inc. is headquartered in the United States.
- Codexis, Inc. was founded in 2010.
- Codexis, Inc. has 2,331 employees.
- Codexis, Inc.'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Codexis, Inc.
Directory pages this company appears in, each with the full list of matching manufacturers.